Legal Representation
Attorney
Andrew N. Fredbeck
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 4, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 4, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 2, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 18, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 28, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 5, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 4, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 4, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 6, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 10, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 10, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 3, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 28, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 31, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 31, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 31, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 11, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical products and therapeutic applications for regenerative medicine, namely, human allograft tissue matrixes derived from amniotic membranes; human allograft tissue; biological tissue grafts; biological amniotic membrane tissue intended for injection for subsequent implantation; injectable medical products, namely, injectable flowable human amniotic membrane allograft; cryopreserved, flowable allograft tissue matrix derived from donated human amniotic membrane
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CP"